Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 27.0B | 27.2B | 24.6B | 15.6B |
Cost of revenue | 23.4B | 23.6B | 21.4B | 13.7B |
Gross profit | 3.6B | 3.7B | 3.1B | 1.9B |
Operating expense | ||||
Research & development | 934.8M | 953M | 896M | 330.9M |
Selling general and admin | 1.3B | 1.3B | 1.2B | 690.8M |
Other operating expenses | — | — | — | — |
Operating income | 1.2B | 1.2B | 870.6M | 769.1M |
Non operating interest income | ||||
Income | 129.4M | 90.7M | 50.3M | 32M |
Expense | 79.4M | 81.2M | 63.2M | 50M |
Other income expense | — | — | — | — |
Pretax income | 228.8M | 605.6M | -67.1M | 276.1M |
Tax provision | 235.3M | 232.4M | 177M | 138.8M |
Net income | -24.2M | 365.6M | -250.4M | 16.2M |
Basic EPS | — | 1.1 | -2.2 | -0.5 |
Diluted EPS | — | 1.1 | -2.2 | -0.5 |
Basic average shares | — | 197.1M | 173.7M | 152.2M |
Diluted average shares | — | 197.1M | 173.7M | 152.2M |
EBITDA | 2.7B | 2.8B | 2.3B | 1.8B |
Net income from continuing op. | 1.4B | 1.4B | 1.1B | 861.7M |
Minority interests | -161M | -143.4M | -131.4M | -95M |
Preferred stock dividends | 0 | 0 | 0 | 0 |